Beximco Pharmaceuticals Limited (LON:BXP)

Healthcare

Incorporated in 1976, Beximco Pharmaceuticals Ltd is a Bangladesh-based emerging generic drug business that provides access to affordable medicines. It initially started as a distributor of importing products from global MNCs such as Bayer, the US, Germany and Upjohn and selling them in local market, which were later manufactured and distributed under licensing agreement. Its manufacturing facilities have been accredited by the leading global regulatory authorities and the medicines produced by the company are exported to over 50 countries including high regulated markets of Australia, Canada, Europe and the US. The company employs over 4,700 employees that includes engineers, accountants, pharmacists, microbiologists, doctors, business graduates, and other professionals. In 1985, the company got listed on the Dhaka Stock Exchange and in 2005, it started trading on the Alternative Investment Market (AIM) of the London Stock Exchange though issuance of GDRs. In 2018, the company acquired 85.22% stake in Nuvista Parma, which is a leading hormone and steroid manufacturer in Bangladesh.

The company is the only Bangladeshi company to export its medicines to the US. However, its majority of revenue comes from Bangladesh. It exports its products across all continents. The company became first in the world to launch generic version of Remdesivir, which is used to treat Covid-19. The company aims to offer contemporary and low-priced medicines that are produced in full compliance with global quality standards to enhance health and well being. The company manufactures over 300 generics, which are available in more than 500 different presentations and number of active pharmaceutical ingredients. The company offers a wide range of products that include analgesics, antacids, oral anti-diabetic, anti-Histamines, anti-Hypertensives, anti-Infectives, anti-Ulcerants, CNS, cough & cold, anti-fungals, enzymes, Gastroprokinetics, Harmones, antispasmodic, respiratory, insulin, IV Fluids, laxatives, lipid lowering, joint supplement, NSAIDs, ophthalmic, urogenital and vitamins & minerals. 

Contact Information

company address 19 Dhanmondi R/A, Road No. 7 1205 Bangladesh

company phone+880.2.58611001

company websitehttps://www.beximcopharma.com/

Similar Companies